Article

Farrant, JP, Schmitt, M, Reid, AB, Garratt, CJ, Newman, WG, Malhotra, A, Beynon, R, Mahmod, M, Raman, B, Cooper, RM, Dawson, D, Green, T, Prasad, SK, Singh, A, Dodd, S, Watkins, H, Neubauer, S and Miller, CA (2024) Considerations for drug trials in hypertrophic cardiomyopathy. ESC Heart Failure.

Williams, NH, Collins, B, Comerford, TJ, Dodd, S, Fisher, M, Hardwick, B, Hennessy, S, Jolly, K, Jones, ID, Lane, DA, Lip, GYH, Morgan, E, Ralph, P, Thijssen, D and Singh, SJ (2024) Effectiveness and cost-effectiveness of a web-based cardiac rehabilitation programme for people with chronic stable angina: protocol for the ACTIVATE (Angina Controlled Trial Investigating the Value of the 'Activate your heart' Therapeutic E-intervention) randomised controlled trial. BMJ Open, 14 (3). pp. 1-11. ISSN 2044-6055

Farrant, J, Dodd, S, Vaughan, C, Reid, A, Schmitt, M, Garratt, C, Akhtar, M, Mahmod, M, Neubauer, S, Cooper, RM, Prasad, SK, Singh, A, Valkovič, L, Raman, B, Ashkir, Z, Clayton, D, Baroja, O, Duran, B, Spowart, C, Bedson, E et al, Naish, JH, Harrington, C, Miller, CA and TEMPEST investigators, (2023) Rationale and design of a randomised trial of trientine in patients with hypertrophic cardiomyopathy. Heart (British Cardiac Society). ISSN 1355-6037